Literature DB >> 11880055

Antibiotic-resistant enterococci: the mechanisms and dynamics of drug introduction and resistance.

Brett D Shepard1, Michael S Gilmore.   

Abstract

Enterococci possess a vast array of mechanisms to resist the lethal effects of most antimicrobial drugs currently approved for therapeutic use in humans, thus presenting a considerable therapeutic challenge. This review summarizes current concepts regarding the mechanisms of resistance, as well as the emergence, proliferation, and epidemiology of resistant enterococci.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11880055     DOI： 10.1016/s1286-4579(01)01530-1

Source DB:  PubMed          Journal:  Microbes Infect        ISSN： 1286-4579            Impact factor:   2.700


  58 in total

1.  Local genetic patterns within a vancomycin-resistant Enterococcus faecalis clone isolated in three hospitals in Portugal.

Authors:  Carla Novais; Teresa M Coque; João Carlos Sousa; Fernando Baquero; Luisa Peixe
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

2.  Antibiotic resistance and virulence factors among clinical and food enterococci isolated in Slovakia.

Authors:  H Drahovská; L Slobodníková; D Kocíncová; M Seman; R Konceková; J Trupl; J Turna
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

3.  Multidrug-resistant enterococci in animal meat and faeces and co-transfer of resistance from an Enterococcus durans to a human Enterococcus faecium.

Authors:  Carla Vignaroli; Giada Zandri; Lucia Aquilanti; Sonia Pasquaroli; Francesca Biavasco
Journal:  Curr Microbiol       Date:  2011-02-01       Impact factor: 2.188

4.  Mechanisms of resistance to daptomycin in Enterococcus faecium.

Authors:  Clemente I Montero; Frida Stock; Patrick R Murray
Journal:  Antimicrob Agents Chemother       Date:  2008-01-07       Impact factor: 5.191

5.  Enterococcus faecalis infection activates phosphatidylinositol 3-kinase signaling to block apoptotic cell death in macrophages.

Authors:  Jun Zou; Nathan Shankar
Journal:  Infect Immun       Date:  2014-09-29       Impact factor: 3.441

Review 6.  Adaptation to Adversity: the Intermingling of Stress Tolerance and Pathogenesis in Enterococci.

Authors:  Anthony O Gaca; José A Lemos
Journal:  Microbiol Mol Biol Rev       Date:  2019-07-17       Impact factor: 11.056

7.  Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: implications for systemic applications.

Authors:  Berthony Deslouches; Kazi Islam; Jodi K Craigo; Shruti M Paranjape; Ronald C Montelaro; Timothy A Mietzner
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

8.  Harnessing bacteriocin biology as targeted therapy in the GI tract.

Authors:  Sushma Kommineni; Christopher J Kristich; Nita H Salzman
Journal:  Gut Microbes       Date:  2016-09-13

9.  Genetic basis for vancomycin-enhanced cephalosporin susceptibility in vancomycin-resistant enterococci revealed using counterselection with dominant-negative thymidylate synthase.

Authors:  Christopher J Kristich; Dusanka Djorić; Jaime L Little
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

Review 10.  Pathogenicity islands in bacterial pathogenesis.

Authors:  Herbert Schmidt; Michael Hensel
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.